Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Torsten Feldt and Björn Jensen.
Torsten Feldt
Connection Strength
0.583
Björn Jensen
  1. Case Report: Convalescent Plasma Achieves SARS-CoV-2 Viral Clearance in a Patient With Persistently High Viral Replication Over 8 Weeks Due to Severe Combined Immunodeficiency (SCID) and Graft Failure. Front Immunol. 2021; 12:645989.
    View in: PubMed
    Score: 0.236
  2. Delayed skin reaction after mRNA-1273 vaccine against SARS-CoV-2: a rare clinical reaction. Eur J Med Res. 2021 Aug 25; 26(1):98.
    View in: PubMed
    Score: 0.060
  3. Informed consent and informed intervention: SARS-CoV-2 vaccinations not just call for disclosure of newly emerging safety data but also for hypothesis generation and testing. Eur J Med Res. 2021 Aug 06; 26(1):87.
    View in: PubMed
    Score: 0.060
  4. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial. Trials. 2021 May 17; 22(1):343.
    View in: PubMed
    Score: 0.059
  5. Measures of infection prevention and incidence of SARS-CoV-2 infections in cancer patients undergoing radiotherapy in Germany, Austria and Switzerland. Strahlenther Onkol. 2020 12; 196(12):1068-1079.
    View in: PubMed
    Score: 0.056
  6. Face masks: benefits and risks during the COVID-19 crisis. Eur J Med Res. 2020 Aug 12; 25(1):32.
    View in: PubMed
    Score: 0.056
  7. The history and value of face masks. Eur J Med Res. 2020 Jun 23; 25(1):23.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.